Optimised Injection Formulation For Mrna

Patent No. EP3153179 (titled "Optimised Injection Formulation For Mrna") was filed by Curevac on May 19, 2006. The application was issued on Jun 19, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ETHERNA IMMUNOTHERAPIESMar 18, 2020ARNOLD & SIEDSMA
BIONTECHMar 16, 2020WILK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3153179

CUREVAC
Application Number
EP16001381A
Filing Date
May 19, 2006
Status
Opposition Rejected
Oct 25, 2024
Publication Date
Jun 19, 2019